News - Page 248 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article NeonMind Superfood Mushroom Coffee Update

NeonMind Superfood Mushroom Coffee Update

Post published:October 20, 2020
Post category:Press Release

Read more about the article Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease

Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease

Post published:October 20, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Post published:October 20, 2020
Post category:Press Release

Read more about the article Cybin Raises $45 Million, Inches Closer to NEO Listing

Cybin Raises $45 Million, Inches Closer to NEO Listing

Post published:October 19, 2020
Post category:Press Release

Read more about the article Psychedelic Bulletin: Swedish Psilocybin for Depression Trial Launches; Numinus Appoints Advisory Council Members; Field Trip Announces Partnership

Psychedelic Bulletin: Swedish Psilocybin for Depression Trial Launches; Numinus Appoints Advisory Council Members; Field Trip Announces Partnership

Post published:October 17, 2020
Post category:Psychedelic Bulletin

Read more about the article Mind Medicine MindMed : MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Mind Medicine MindMed : MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Post published:October 16, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

Post published:October 16, 2020
Post category:Press Release

Read more about the article First Psilocybin for Depression Clinical Trial Launched in Sweden

First Psilocybin for Depression Clinical Trial Launched in Sweden

Post published:October 16, 2020
Post category:Clinical Trials News

Read more about the article Mind Cure Announces Geoff Belair as Chief Technology Officer

Mind Cure Announces Geoff Belair as Chief Technology Officer

Post published:October 15, 2020
Post category:Press Release

Read more about the article Heroic Hearts Project and Field Trip Health Ltd. enter into a strategic relationship to increase legal psychedelic therapy access for military veterans in North America

Heroic Hearts Project and Field Trip Health Ltd. enter into a strategic relationship to increase legal psychedelic therapy access for military veterans in North America

Post published:October 14, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.